Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells von Oh, Sangwook, Mao, Xuming, Manfredo-Vieira, Silvio, Lee, Jinmin, Patel, Darshil, Choi, Eun Jung, Alvarado, Andrea, Cottman-Thomas, Ebony, Maseda, Damian, Tsao, Patricia Y., Ellebrecht, Christoph T., Khella, Sami L., Richman, David P., O’Connor, Kevin C., Herzberg, Uri, Binder, Gwendolyn K., Milone, Michael C., Basu, Samik, Payne, Aimee S.

Volltext

Muscle-Specific Kinase Myasthenia Gravis von Borges, Lucia S, Richman, David P

Volltext

Myasthenia gravis and related disorders: Pathology and molecular pathogenesis von Ha, James C., Richman, David P.

Volltext

International consensus guidance for management of myasthenia gravis: Executive summary von Sanders, Donald B, Wolfe, Gil I, Benatar, Michael, Evoli, Amelia, Gilhus, Nils E, Illa, Isabel, Kuntz, Nancy, Massey, Janice M, Melms, Arthur, Murai, Hiroyuki, Nicolle, Michael, Palace, Jacqueline, Richman, David P, Verschuuren, Jan, Narayanaswami, Pushpa

Volltext

Thymectomy and myasthenia gravis von Lisak, Robert P., Richman, David P.

Volltext

Treatment of myasthenia gravis based on its immunopathogenesis von Kim, Jee Young, Park, Kee Duk, Richman, David P

Volltext

Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator von Bissig, David, MD, PhD, Manjunath, Rashmi, MD, Traylor, Brittany R., PharmD, Richman, David P., MD, Ng, Kwan L., MD, PhD

Volltext

The Future of Research in Myasthenia von Richman, David P

Volltext

Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study von Nowak, Richard J., Coffey, Christopher S., Goldstein, Jonathan M., Dimachkie, Mazen M., Benatar, Michael, Kissel, John T., Wolfe, Gil I., Burns, Ted M., Freimer, Miriam L., Nations, Sharon, Granit, Volkan, Smith, A. Gordon, Richman, David P., Ciafaloni, Emma, Al-Lozi, Muhammad T., Sams, Laura Ann, Quan, Dianna, Ubogu, Eroboghene, Pearson, Brenda, Sharma, Aditi, Yankey, Jon W., Uribe, Liz, Shy, Michael, Amato, Anthony A., Conwit, Robin, O'Connor, Kevin C., Hafler, David A., Cudkowicz, Merit E., Barohn, Richard J.

Volltext

Myasthenia gravis exacerbation after discontinuing mycophenolate: A single-center cohort study von Oskarsson, Björn, Rocke, David M, Dengel, Karsten, Richman, David P

Volltext

Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells von Oh, Sangwook, Mao, Xuming, Manfredo-Vieira, Silvio, Lee, Jinmin, Patel, Darshil, Choi, Eun Jung, Alvarado, Andrea, Cottman-Thomas, Ebony, Maseda, Damian, Tsao, Patricia Y., Ellebrecht, Christoph T., Khella, Sami L., Richman, David P., O’Connor, Kevin C., Herzberg, Uri, Binder, Gwendolyn K., Milone, Michael C., Basu, Samik, Payne, Aimee S.

Volltext

3,4‐diaminopyridine base effectively treats the weakness of Lambert‐Eaton myasthenia von Sanders, Donald B., Juel, Vern C., Harati, Yadollah, Smith, A. Gordon, Peltier, Amanda C., Marburger, Tessa, Lou, Jau‐Shin, Pascuzzi, Robert M., Richman, David P., Xie, Tai, Demmel, Valentin, Jacobus, Laura R., Aleš, Kathy L., Jacobus, David P.

Volltext

Treatment of autoimmune myasthenia gravis von RICHMAN, David P, AGIUS, Mark A

Volltext

Enrichment of serum IgG4 in MuSK myasthenia gravis patients von Vergoossen, Dana L.E., Ruiter, Annabel M., Keene, Kevin R., Niks, Erik H., Tannemaat, Martijn R., Strijbos, Ellen, Lipka, Alexander F., van der Zijde, Els C. Jol, van Tol, Maarten J.D., Bakker, Jaap A., Wevers, Brigitte A., Westerberg, Elisabet, Borges, Lúcia S., Tong, Olivia C., Richman, David P., Illa, Isabel, Punga, Anna Rostedt, Evoli, Amelia, van der Maarel, Silvère M., Verschuuren, Jan J., Huijbers, Maartje G.

Volltext

Thymectomy in the treatment of ocular myasthenia gravis von Roberts, Peter F., Venuta, Federico, Rendina, Erino, De Giacomo, Tiziana, Coloni, Giorgio F., Follette, David M., Richman, David P., Benfield, John R.

Volltext

How clinical trials of myasthenia gravis can inform pre-clinical drug development von Rostedt Punga, Anna, Kaminski, Henry J., Richman, David P., Benatar, Michael

Volltext

Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren’s syndrome von Kim, Susan S, Richman, David P, Johnson, Wesley O, Hald, John K, Agius, Mark A

Volltext

Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma von Lara, Matthew S., Afify, Alaa, Ellis, Michael P., Phan, Chinh T., Richman, David P., Riess, Jonathan W.

Volltext

Validation of the triple timed up‐and‐go test in Lambert‐Eaton myasthenia von Raja, Shruti M., Sanders, Donald B., Juel, Vern C., Harati, Yadollah, Smith, A. Gordon, Pascuzzi, Robert, Richman, David P., Wu, Angie, Aleš, Kathy L., Jacobus, Laura R., Jacobus, David P., Guptill, Jeffrey T.

Volltext

Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice von Kim, Susan S, Richman, David P, Zamvil, Scott S, Agius, Mark A

Volltext